To include your compound in the COVID-19 Resource Center, submit it here.

Crestor rosuvastatin: NDA submitted

AZN denied rumors that the FDA requested that the company start new trials of Crestor in order to gain approval of the cholesterol treatment. AZN said

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE